J&J | JNJ - Operating Profit

Stock Price
239.58
Daily Change
1.79 0.75%
Monthly
15.47%
Yearly
56.47%
Q1 Forecast
220.25

J&J reported $5.59B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Abbott USD 2.25B 73M Dec/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Bayer EUR -543M 556M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
CONMED USD 36.62M 24.74M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Hologic USD 237M 16M Dec/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merck USD 6.24B 318M Dec/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025
Zoetis USD 936M 63M Sep/2025